{"study_desc":{"title_statement":{"idno":"FRESH-PEF5321-en","IDno":{"metadata_no":[{"agency":"PEF","code":"5321"},{"agency":"FReSH","code":"FRESH-PEF5321"}]},"title":"Cross-Sectional Study on Female BRCA1\/2 Mutation Carriers: Genetic Modifiers of Cancer Risk","alternate_title":"GEMO"},"study_authorization":{"agency":[{"name":"CNIL"}]},"authoring_entity":[{"name":"Olga;SINILNIKOVA-ERARD","firstname":"Olga","lastname":"SINILNIKOVA-ERARD","type":"investigator","extlink":[{"title":"ROR","uri":"https:\/\/ror.org\/01rk35k63","role":"organisation id"}],"email":"olga.sinilnikova@lyon.unicancer.fr","affiliationName":"UNIVERSITE DE LYON","PILabo":"INSERM\/CNRS\/CLB\/UNIVERSITE DE LYON\/HOSPICES CIVILS DE \/ Centre de Recherche en Canc\u00e9rologie UMR5286 CNRS \/ U1052 Inserm, Equipe \u00ab G\u00e9n\u00e9tique du cancer du sein \u00bbUnit\u00e9 Mixte de G\u00e9n\u00e9tique Constitutionnelle des Cancers Fr\u00e9quents, Hospices Civils de Lyon - Centre L\u00e9on B\u00e9rard","isContact":true},{"name":"Dominique;STOPPA-LYONNET","firstname":"Dominique","lastname":"STOPPA-LYONNET","type":"investigator","extlink":[{"title":"ROR","uri":"https:\/\/ror.org\/05f82e368","role":"organisation id"},{"title":"SIREN","uri":"130025737","role":"organisation id"},{"uri":"0000-0002-5438-8309","role":"pi id","title":"ORCID"},{"uri":"050298550","role":"pi id","title":"IdRef"}],"email":"","affiliationName":"UNIVERSITE PARIS CITE","PILabo":"INSTITUT CURIE\/INSERM\/UNIVERSITE PARIS \/ Centre de Recherche INSERM U830, D\u00e9partement de Biologie des tumeurs - Service G\u00e9n\u00e9tique","isContact":false}],"oth_id":[{"name":""}],"production_statement":{"prod_place":"Epidemiology France Portal (PEF)","producers":[{"name":"UniCancer Group","extlink":[{"title":"ROR","uri":"https:\/\/ror.org\/04vhgtv41","role":"sponsor id"}],"role":"sponsor"}],"funding_agencies":[{"name":""}]},"distribution_statement":{"contact":[{"name":"Olga;SINILNIKOVA-ERARD","lastname":"SINILNIKOVA-ERARD","firstname":"Olga","type":"contact","email":"olga.sinilnikova@lyon.unicancer.fr","affiliationName":"UNIVERSITE DE LYON","contactPointLabo":"","extlink":[{"uri":"https:\/\/ror.org\/01rk35k63","role":"organisation id","title":"ROR"}]}]},"study_info":{"keywords":[{"keyword":"alleles"},{"keyword":"changes"},{"keyword":"loci"},{"keyword":"cancer risk"}],"topics":[{"topic":"Oncology","vocab":"health theme","extLink":[{"title":"ESV","uri":"http:\/\/data.europa.eu\/8mn\/euroscivoc\/5784b7f1-c7ce-49d9-9f38-aebcda0ff41d"},{"title":"MeSH","uri":"D008495"}]},{"topic":"Biological determinants: Genetic predisposition","vocab":"health determinant"},{"topic":"Biological determinants","vocab":"health determinant"}],"purpose":"To identify the various loci associated with changes in cancer risk and to identify women from our samples with alleles associated with increased or decreased cancer risk.","abstract":"","coll_dates":[{"start":"2002-01-01"}],"nation":[{"name":"France","abbreviation":"fr","extLink":{"vocab":"ISO","vocabURI":"fr"}}],"geog_coverage":"","analysis_unit":"Individuals","universe":"{\"level_sex_clusion_I\":[{\"value\":\"Female\",\"concept\":{\"vocab\":\"MeSH\",\"vocabURI\":\"D005260\"}}],\"level_age_clusion_I\":[{\"value\":\"Young Adult (19 to 24 years)\",\"concept\":{\"vocab\":\"MeSH\",\"vocabURI\":\"D055815\"}},{\"value\":\"Adult (25 to 44 years)\",\"concept\":{\"vocab\":\"MeSH\",\"vocabURI\":\"D000328\"}},{\"value\":\"Middle Aged (45 to 64 years)\",\"concept\":{\"vocab\":\"MeSH\",\"vocabURI\":\"D008875\"}},{\"value\":\"Aged (65 to 79 years)\",\"concept\":{\"vocab\":\"MeSH\",\"vocabURI\":\"D000368\"}},{\"value\":\"Aged, 80 and over (80 years and more)\",\"concept\":{\"vocab\":\"MeSH\",\"vocabURI\":\"D000369\"}}],\"level_type_clusion_I\":\"Patients population\",\"level_type_clusion_other\":\"\",\"clusion_I\":\"Female BRCA1\/2 mutation carriers who had breast and\/or ovarian cancer or are cancer-free.\",\"clusion_E\":\"\"}","data_kind":"['Clinical data','Paraclinical data (non-biological)','Biological data']","quality_statement":{"standards":[{"name":"","committee":"","governance":""}],"other_quality_statement":""}},"study_development":{"development_activity":[{"activity_type":"primary evaluation","activity_description":"Health event\/morbidity\r\nHealth event\/mortality"}]},"method":{"data_collection":{"time_method":"One-time cross-sectional study","frequency":"","sampling_procedure":"['{\"concept\":{\"vocabURI\":\"Other\",\"vocab\":\"CESSDA\"},\"value\":\"Other\"}']","sample_frame":{"frame_unit":{"unit_type":"['Through organizations (health services or institutions, schools, businesses, etc.)']"}},"coll_mode":["{\"concept\":{\"vocabURI\":\"Other\",\"vocab\":\"CESSDA\"},\"value\":\"Other\"}"],"research_instrument":"Access on specific project only","sources":[],"target_sample_size":"[1000-10000[ individuals","response_rate":"3661(BRCA1 : 2471 ; BRCA2 : 1190)."},"method_notes":"Observational Study","study_class":"Completed study","notes":[{"subject":"research type","values":["Observational Study"]}]},"data_access":{"dataset_availability":{"access_place":"","complete":"","status":"{\"value\":\"To be defined\",\"extLink\":[]}","notes":""},"dataset_use":{"restrictions":"","conditions":"","conf_dec":[{"txt":""}],"spec_perm":[{"txt":"","required":""}],"contact":[{"name":""}],"deposit_req":"","cit_req":""}}},"additional":{"versionLang":"en","originLang":"en","autoTranslation":false,"status":"Imported","creationDate":"04-01-2013","lastUpdatedManual":"07-07-2014","isContributorPI":"","contributorName":"","contributorAffiliation":"","addTeamMember":"","obtainedAuthorization":{"otherAuthorizingAgency":[""]},"relatedDocument":[{"type":"","title":"","link":"http:\/\/ccge.medschl.cam.ac.uk\/consortia\/cimba\/"}],"regulatoryRequirements":{"conformityDeclaration":""},"fundingAgent":{"fundingAgentType":[],"otherFundingAgentType":[]},"sponsor":{"sponsorType":["Private non-profit"],"otherSponsorType":[""]},"governance":{"committee":""},"collaborations":{"networkConsortium":""},"theme":{"complementaryInformation":"","RareDiseases":""},"activeFollowUp":{"isActiveFollowUp":false,"followUpModeOther":""},"interventionalStudy":{"researchPurpose":[],"trialPhase":[],"interventionalStudyModel":"","isClinicalTrial":"","otherResearchPurpose":""},"isInclusionGroups":"","allocation":{"allocationMode":"","allocationUnit":""},"masking":{"maskingType":"","blindedMaskingDetails":[]},"arms":[],"intervention":[],"inclusionGroups":[],"collectionProcess":{"collectionModeDetails":"By the genetic oncologist monitoring the patient.","collectionModeOther":""},"dataCollection":{"inclusionStrategyOther":"","samplingModeOther":"","recruitmentSourceOther":"","otherDocumentation":""},"dataCollectionIntegration":{"isDataIntegration":false},"geographicalCoverage":{"geoDetail":"France"},"dataTypes":{"clinicalDataDetails":"","biologicalDataDetails":"Description of BRCA1\/BRCA2 mutation.","isDataInBiobank":true,"biobankContent":[],"biobankContentOther":"","dataTypeOther":""},"variableDictionnary":{"variableDictionnaryAvailable":"","variableDictionnaryLink":""},"dataQuality":{"otherDocumentation":""},"mockSample":{"mockSampleAvailable":"","mockSampleLocation":""},"thirdPartySource":{"otherSourceType":[]},"isHealthTheme":true,"fileDscr":{"fileTxt":{"fileCitation":{"titlStmt":{"IDno":[]}}}}},"schematype":"survey"}